» Articles » PMID: 33717157

Complement Has Brains-Do Intracellular Complement and Immunometabolism Cooperate in Tissue Homeostasis and Behavior?

Overview
Journal Front Immunol
Date 2021 Mar 15
PMID 33717157
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The classical liver-derived and serum-effective complement system is well appreciated as a key mediator of host protection instruction of innate and adaptive immunity. However, recent studies have discovered an intracellularly active complement system, the complosome, which has emerged as a central regulator of the core metabolic pathways fueling human immune cell activity. Induction of expression of components of the complosome, particularly complement component C3, during transmigration from the circulation into peripheral tissues is a defining characteristic of monocytes and T cells in tissues. Intracellular complement activity is required to induce metabolic reprogramming of immune cells, including increased glycolytic flux and OXPHOS, which drive the production of the pro-inflammatory cytokine IFN-γ. Consequently, reduced complosome activity translates into defects in normal monocyte activation, faulty Th1 and cytotoxic T lymphocyte responses and loss of protective tissue immunity. Intriguingly, neurological research has identified an unexpected connection between the physiological presence of innate and adaptive immune cells and certain cytokines, including IFN-γ, in and around the brain and normal brain function. In this opinion piece, we will first review the current state of research regarding complement driven metabolic reprogramming in the context of immune cell tissue entry and residency. We will then discuss how published work on the role of IFN-γ and T cells in the brain support a hypothesis that an evolutionarily conserved cooperation between the complosome, cell metabolism and IFN-γ regulates organismal behavior, as well as immunity.

Citing Articles

Low CD46 expression on activated CD4 T cells predict improved Th1 cell reactivity to calcitriol in majority of patients with allergic eosinophilic asthma and healthy donors.

Stichova J, Slanina P, Chovancova Z, Baros J, Litzman M, Litzman J Front Allergy. 2024; 5:1462579.

PMID: 39403120 PMC: 11472004. DOI: 10.3389/falgy.2024.1462579.


C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer's disease mouse model.

Schartz N, Liang H, Carvalho K, Chu S, Mendoza-Arvilla A, Petrisko T Nat Commun. 2024; 15(1):7028.

PMID: 39147742 PMC: 11327341. DOI: 10.1038/s41467-024-51163-6.


Glycolytic dysregulation in Alzheimer's disease: unveiling new avenues for understanding pathogenesis and improving therapy.

Wu Y, Yang L, Jiang W, Zhang X, Yao Z Neural Regen Res. 2024; 20(8):2264-2278.

PMID: 39101629 PMC: 11759019. DOI: 10.4103/NRR.NRR-D-24-00190.


The complement system in neurodegenerative and inflammatory diseases of the central nervous system.

Negro-Demontel L, Maleki A, Reich D, Kemper C Front Neurol. 2024; 15:1396520.

PMID: 39022733 PMC: 11252048. DOI: 10.3389/fneur.2024.1396520.


The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)-What Future Prospects Are There for Its Use in Clinical Practice?.

Panebianco M, Ciccarese C, Strusi A, Beccia V, Carbone C, Agostini A Cancers (Basel). 2024; 16(3).

PMID: 38339243 PMC: 10854780. DOI: 10.3390/cancers16030490.


References
1.
Merle N, Singh P, Rahman J, Kemper C . Integrins meet complement: The evolutionary tip of an iceberg orchestrating metabolism and immunity. Br J Pharmacol. 2020; 178(14):2754-2770. PMC: 8359198. DOI: 10.1111/bph.15168. View

2.
Lalli P, Strainic M, Yang M, Lin F, Medof M, Heeger P . Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood. 2008; 112(5):1759-66. PMC: 2518884. DOI: 10.1182/blood-2008-04-151068. View

3.
Astier A, Meiffren G, Freeman S, Hafler D . Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest. 2006; 116(12):3252-7. PMC: 1635165. DOI: 10.1172/JCI29251. View

4.
Morimoto K, Nakajima K . Role of the Immune System in the Development of the Central Nervous System. Front Neurosci. 2019; 13:916. PMC: 6735264. DOI: 10.3389/fnins.2019.00916. View

5.
Rahman J, Singh P, Merle N, Niyonzima N, Kemper C . Complement's favourite organelle-Mitochondria?. Br J Pharmacol. 2020; 178(14):2771-2785. PMC: 8359399. DOI: 10.1111/bph.15238. View